KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Current Taxes (2016 - 2025)

Globus Medical (GMED) has disclosed Current Taxes for 15 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Taxes fell 61.26% year-over-year to $4.2 million, compared with a TTM value of $4.2 million through Dec 2025, down 61.26%, and an annual FY2025 reading of $4.2 million, down 61.26% over the prior year.
  • Current Taxes was $4.2 million for Q4 2025 at Globus Medical, up from $1.3 million in the prior quarter.
  • Across five years, Current Taxes topped out at $43.1 million in Q1 2024 and bottomed at $1.3 million in Q3 2025.
  • Average Current Taxes over 5 years is $13.4 million, with a median of $10.1 million recorded in 2022.
  • The sharpest move saw Current Taxes skyrocketed 2530.12% in 2023, then tumbled 87.87% in 2024.
  • Year by year, Current Taxes stood at $6.4 million in 2021, then soared by 56.34% to $10.0 million in 2022, then skyrocketed by 136.57% to $23.7 million in 2023, then crashed by 54.8% to $10.7 million in 2024, then plummeted by 61.26% to $4.2 million in 2025.
  • Business Quant data shows Current Taxes for GMED at $4.2 million in Q4 2025, $1.3 million in Q3 2025, and $38.9 million in Q2 2025.